Trajectories of fatigue in actively treated patients with established rheumatoid arthritis starting biologic DMARD therapy.
Sella Aarrestad ProvanBrigitte MichelsenJoseph SextonTillmann UhligHilde Berner HammerPublished in: RMD open (2021)
A trajectory of continued fatigue was determined by PROMs and not by inflammatory RA disease activity.